等待开盘 07-30 09:30:00 美东时间
-0.063
-2.10%
https://www.wsj.com/health/healthcare/medicare-part-d-drug-plan-premiums-set-to-rise-16ef919c
07-29 04:29
TSLAUNHAEORKTGOOGLCLOVFUBOGOOGDNUTGLDData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
07-24 21:19
An update from TotalEnergies SE ( ($FR:TTE) ) is now available. TotalEnergies h...
07-23 21:47
The meme stock rally is resurfacing as equity markets continue to hit new highs. It's being bolstered by optimism over economic data, trade deals, and expectations for a coming Fed easing cycle. Earni...
07-23 19:15
Gainers Medpace Hldgs (NASDAQ:MEDP) shares moved upwards by 44.6% to $446.6 du...
07-22 20:07
Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) rose sharply in pre-market tradi...
07-22 17:39
Billionaire venture capitalist Chamath Palihapitiya took to X to share his thoughts on the stock market and offer some advice to investors. What Happened: On Sunday, Palihapitiya posted about a trade idea he had shared on the All In Podcast in January.
07-21 21:08
Clover Health Investments, Corp. announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 11:00 a.m. ET. The presentation will be available via live webcast and replay on Clover Health's investor relations website. Clover Health is a technology company focused on improving Medicare access through its software platform, Clover Assistant, which aggregates p...
07-21 20:05
Clover Health announced the appointment of Joe Oldakowski as Vice President of Finance and Controller. With nearly 20 years of experience in finance and accounting leadership, Oldakowski will oversee corporate accounting, financial reporting, and tax functions. His expertise in healthcare and insurance finance, including leading complex transformations, will support Clover’s mission to improve healthcare access and outcomes for Medicare patients.
07-17 12:30
SELLAS Life Sciences (NASDAQ:SLS) traded higher in the premarket on Tuesday after the New York-based biotech said that a Phase 2 trial that tested its antitumor agent SLS009 (tambiciclib) as part of a...
07-15 20:22